Nuveen Asset Management’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $594K | Sell |
192,259
-12,562
| -6% | -$38.8K | ﹤0.01% | 2925 |
|
|
2024
Q3 | $1.58M | Sell |
204,821
-449
| -0.2% | -$3.46K | ﹤0.01% | 2538 |
|
|
2024
Q2 | $1.76M | Sell |
205,270
-143,066
| -41% | -$1.23M | ﹤0.01% | 2446 |
|
|
2024
Q1 | $2.77M | Sell |
348,336
-71,210
| -17% | -$565K | ﹤0.01% | 2253 |
|
|
2023
Q4 | $4.15M | Buy |
419,546
+238,077
| +131% | +$2.36M | ﹤0.01% | 2080 |
|
|
2023
Q3 | $2.04M | Buy |
181,469
+10,246
| +6% | +$115K | ﹤0.01% | 2285 |
|
|
2023
Q2 | $568K | Buy |
171,223
+9,440
| +6% | +$31.3K | ﹤0.01% | 2873 |
|
|
2023
Q1 | $639K | Sell |
161,783
-6,780
| -4% | -$26.8K | ﹤0.01% | 2749 |
|
|
2022
Q4 | $1.22M | Buy |
168,563
+5,363
| +3% | +$38.9K | ﹤0.01% | 2605 |
|
|
2022
Q3 | $591K | Sell |
163,200
-134
| -0.1% | -$485 | ﹤0.01% | 2923 |
|
|
2022
Q2 | $740K | Buy |
163,334
+119,055
| +269% | +$539K | ﹤0.01% | 2912 |
|
|
2022
Q1 | $338K | Buy |
+44,279
| New | +$338K | ﹤0.01% | 3100 |
|